Vous avez cherché: glimepiride (Anglais - Estonien)

glimepiride
glimepiriid

pioglitazone glimepiride
pioglitasoon glimepiriid

glimepiride 4 mg/day
glimepiriid 4 mg/ööpäev

risk related to glimepiride
glimepiriidiga seotud risk

+ glimepiride 4 mg daily
4 mg ööpäevas

avaglim rosiglitazone and glimepiride
avaglim rosiglitasoon ja glimepiriid

glimepiride is transferred to the placenta.
glimepiriid läbib platsentaarbarjääri.

8 mg rosiglitazone and 4 mg glimepiride).
4 mg rosiglitasooni ja 4 mg glimepiriidi; punased 8 mg rosiglitasooni ja 4 mg glimepiriidi).

add-on to glimepiride (4 mg/day)
lisatuna glimepiriidile (4 mg/ööpäev)

in animals, glimepiride is excreted in milk.
katseloomadel eritub glimepiriid piimaga.

the active substances are pioglitazone and glimepiride.
toimeained on pioglitasoon ja glimepiriid.

4 mg rosiglitazone and 4 mg glimepiride; red:
ravimit turustatakse kolmnurksete tablettidena (roosad:

glimepiride (titrated) + metformin (n = 482)
glimepiriid (tiitritud) + metformiin (n = 482)

for glimepiride, information from scientific publications was used.
teave glimepiriidi kohta pärineb teaduslikest väljaannetest.

glimepiride has also been available in the eu since 1995.
glimperiidi on elis turustatud alates 1995. aastast.

vildagliptin 50 mg daily + glimepiride (n=132)
vildagliptiin 50 mg ööpäevas + glimepiriid (n=132)

sulphonylurea-derivatives like glimepiride pass into the breast milk.
sulfonüüluurea derivaadid, sealhulgas glimepiriid, erituvad rinnapiima.

difference from glimepiride (adjusted mean) (95% ci)
erinevus võrreldes glimepiriidiga (kohandatud keskmine) (95% ci)

glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
glimepiriid stimuleerib peamiselt insuliini vabanemist pankrease beetarakkudest.

avaglim 4 mg/4 mg film-coated tablets. rosiglitazone/glimepiride
avaglim 4 mg/4 mg õhukese polümeerikattega tabletid. rosiglitasoon/glimepiriid